UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The Journal of pathology, ISSN 0022-3417, 04/2018, Volume 244, Issue 4, pp. 394 - 407
nasopharyngeal carcinoma | ATM serine/threonine kinase (ATM) | transcriptome sequencing | Epstein–Barr virus | EBV‐miRNAs | EBV-miRNAs | Pathology | Oncology | Life Sciences & Biomedicine | Science & Technology | Nasopharyngeal Neoplasms - genetics | Herpesvirus 4, Human - genetics | Virus Latency | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Nasopharyngeal Neoplasms - virology | Transcriptome | Male | Nasopharyngeal Neoplasms - pathology | Nasopharyngeal Carcinoma - enzymology | Nasopharyngeal Carcinoma - virology | Heterografts | RNA, Viral - genetics | Ataxia Telangiectasia Mutated Proteins - biosynthesis | Female | 3' Untranslated Regions | Binding Sites | Epstein-Barr Virus Infections - virology | Nasopharyngeal Neoplasms - enzymology | Host-Pathogen Interactions | Animals | Nasopharyngeal Carcinoma - genetics | Mice, Nude | Nasopharyngeal Carcinoma - pathology | Cell Line, Tumor | Epstein-Barr Virus Infections - diagnosis | MicroRNAs - genetics | DNA Damage | Ataxia Telangiectasia Mutated Proteins - genetics | Enzyme Repression | Carcinoma | MicroRNA | Analysis | Cancer | Transcription | Xenotransplantation | DNA damage | Viruses | Activation | Malignancy | Tissues | Gene sequencing | Nasopharyngeal carcinoma | Signal transduction | Transfection | Xenografts | Ataxia | miRNA | Tumorigenesis | Deoxyribonucleic acid--DNA | Tumor cells | Invasiveness | Double-strand break repair | Gene expression | Ribonucleic acid--RNA | Latency | Signaling | 3' Untranslated regions | Ataxia telangiectasia mutated protein | Tumors | Index Medicus | threonine kinase (ATM) | Original Papers | Original Paper | ATM serine
Journal Article
Scientific reports, ISSN 2045-2322, 11/2019, Volume 9, Issue 1, pp. 16814 - 9
Journal Article
American journal of human genetics, ISSN 0002-9297, 01/2013, Volume 92, Issue 1, pp. 41 - 51
Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | Genetic Predisposition to Disease | Genome-Wide Association Study | B7-1 Antigen - genetics | Humans | Asian Continental Ancestry Group - genetics | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Membrane Proteins | Proteins - genetics | Dioxygenases - genetics | Lupus Erythematosus, Systemic - ethnology | Lupus Erythematosus, Systemic - genetics | Polymorphism, Single Nucleotide | Cyclin-Dependent Kinase Inhibitor p27 - genetics | DNA replication | Systemic lupus erythematosus | Genetic susceptibility | Causes of | Genetic aspects | Heritability | Research | Human population genetics | Asians | Diseases | Lupus | Analysis | Pathogenesis | Genetics | Gene loci | Cultural differences | Meta-analysis | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 07/2014, Volume 371, Issue 5, pp. 434 - 446
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Graft vs Host Disease - epidemiology | Humans | Severe Combined Immunodeficiency - mortality | Severe Combined Immunodeficiency - therapy | Infant | Male | Survival Rate | Treatment Outcome | Severe Combined Immunodeficiency - immunology | Hematopoietic Stem Cell Transplantation - mortality | Incidence | Retreatment | CD3 Complex - blood | Hematopoietic Stem Cell Transplantation - adverse effects | Immunoglobulin A - blood | Lymphocyte Count | Female | T-Lymphocytes - immunology | Retrospective Studies | Transplantation Conditioning | Siblings | Transplantation of organs, tissues, etc | Research | Health aspects | Patient outcomes | Reorganization and restructuring | Immunodeficiency | Cell proliferation | Cell survival | Severe combined immunodeficiency | Transplants & implants | Hypersensitivity | Infections | Infants | Lymphocytes T | Transplantation | CD3 antigen | Immunoglobulin A | Hemopoiesis | CD4 antigen | Infectious diseases | Donors | Stem cells | Bone marrow | Children | Immune system | Index Medicus | Abridged Index Medicus
Journal Article
Nature communications, 01/2017, Volume 8, p. 14121
Journal Article
6.
Full Text
Specific targeting of point mutations in EGFR L858R-positive lung cancer by CRISPR/Cas9
Laboratory investigation, ISSN 0023-6837, 07/2018, Volume 98, Issue 7, pp. 968 - 976
Pathology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Lung Neoplasms - genetics | Point Mutation - genetics | DNA Mutational Analysis | Humans | ErbB Receptors - genetics | Cell Line, Tumor | Lung Neoplasms - therapy | CRISPR-Cas Systems - genetics | DNA Cleavage | Genetic Therapy - methods | Cell proliferation | CRISPR | Epidermal growth factor receptors | Nucleotide sequence | Lung cancer | Genomes | Gene sequencing | Proteins | Point mutation | Strategy | Cleavage | Mutation | Endonuclease | Deoxyribonucleic acid--DNA | Cancer | Index Medicus
Journal Article
The lancet respiratory medicine, ISSN 2213-2600, 07/2020, Volume 8, Issue 7, pp. 687 - 695
Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Pandemics | Humans | Middle Aged | Coronavirus Infections - physiopathology | Male | Respiratory Mucosa - virology | Betacoronavirus - immunology | COVID-19 | Respiratory System - virology | SARS-CoV-2 | Betacoronavirus - physiology | Respiratory Mucosa - immunology | Aged, 80 and over | Adult | Female | Respiratory Mucosa - physiopathology | Respiratory System - immunology | Viral Tropism - physiology | Conjunctiva - immunology | Conjunctiva - physiopathology | Conjunctiva - virology | Coronavirus Infections - immunology | Pneumonia, Viral - immunology | Pneumonia, Viral - physiopathology | Immunity, Innate - immunology | Respiratory System - physiopathology | Aged | Virus Replication - physiology | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 05/2020, Volume 395, Issue 10238, pp. 1695 - 1704
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antiviral agents | Product development | Biological response modifiers | Lopinavir | Viral antigens | Interferon beta | Therapy | Pandemics | Laboratories | Ritonavir | Health services | Viral diseases | Population studies | Infections | Middle East respiratory syndrome | Ribavirin | COVID-19 | Hepatitis | Randomization | Drug dosages | Signs and symptoms | Bacterial infections | Cytokines | Severe acute respiratory syndrome | Diarrhea | Nausea | Coronaviruses | Patients | Severe acute respiratory syndrome coronavirus 2 | Polymerase chain reaction | Influenza | Respiratory diseases | Interferon | Mutation | Index Medicus | Abridged Index Medicus
Journal Article